Pre-booster and post-booster seroprevalence of measles antibodies among employees of the Olomouc University Hospital - a pilot study

被引:0
作者
Stepanek, Lad [1 ,2 ]
Vecerova, R. [2 ,3 ]
Sauer, P. [2 ,3 ]
Stepanek, Lub [4 ]
Kolar, M. [2 ,3 ]
Nakladalova, M. [1 ,2 ]
机构
[1] Univ Palackeho Olomouci, Lekarska Fak, Klin Pracovniho Lekarstvi, IP Pavlova 185-6, Olomouc 77900, Czech Republic
[2] Fak Nemocnice Olomouc, IP Pavlova 185-6, Olomouc 77900, Czech Republic
[3] Univ Palackeho Olomouci, Lekarska Fak, Ustav Mikrobiol, Olomouc, Czech Republic
[4] Univ Karlovy, Ustav Biofyziky & Informatiky, Lekarska Fak 1, Prague, Czech Republic
来源
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE | 2021年 / 70卷 / 02期
关键词
measles; booster dose; seroprevalence; seroconversion; HEALTH-CARE WORKERS; VACCINE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: The increase in measles cases in early 2019 led to the implementation of several preventive measures focused mainly on health care providers. The study aimed to evaluate the seroprevalence of measles antibodies among employees of a large hospital and, a year apart, the rate of seroconversion in a pilot sample of the revaccinated subjects. Methods: In 3027 employees of the University Hospital Olomouc, specific immunoglobulin G levels were tested on a voluntary basis. Those with insufficient levels were offered a booster dose. About approximately one year after the booster dose, the same test was performed in a sample of 52 employees. Results: Of the tested subjects with a mean age of 41.8 +/- 9.2 years, 54.0% were seropositive. A higher proportion of seropositivity as well as higher absolute values of antibody titers were noted in those born before routine vaccination was introduced in 1969. A total of 80.9% of the seronegative subjects opted for a booster dose. Seroconversion occurred in 73.2% of retested subjects. The relative increase of post-booster antibody titers was moderately correlated with age (r = 0.47, p < 0.05). Conclusion: The proportion of seronegative employees of a large hospital reached 46.0%, being higher in younger individuals. Seroconversion occurred in 73.2% of booster dose recipients included in a pilot sample for reanalysis. A statistically significant correlation was noted between the relative increase of antibody titers and age.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 2020, IMM VACC BIOL
[2]   Seek and hide: the manipulating interplay of measles virus with the innate immune system [J].
Ayasoufi, Katayoun ;
Pfaller, Christian K. .
CURRENT OPINION IN VIROLOGY, 2020, 41 :18-30
[3]   Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study [J].
Bianchi, Francesco Paolo ;
Stefanizzi, Pasquale ;
De Nitto, Sara ;
Larocca, Angela Maria Vittoria ;
Germinario, Cinzia ;
Tafuri, Silvio .
JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (05) :721-728
[4]   Preliminary Report of Seroprevalence of Anti-Measles Immunoglobulin G among Healthcare Workers of 6 Teaching Hospitals of Daegu, Korea in 2019 [J].
Chang, Hyun-Ha ;
Kim, Shin-Woo ;
Kwon, Ki Tae ;
Kim, Hye In ;
Kim, Min Jung ;
Ryu, Seong Yeol ;
Kim, Hyun Ah ;
Hur, Jian ;
Kwon, Hyun Hee ;
Hong, Hyo-Lim .
INFECTION AND CHEMOTHERAPY, 2019, 51 (01) :54-57
[5]   Measles immunity in an Italian teaching hospital [J].
Coppeta, L. ;
Pietroiusti, A. ;
Lieto, P. ;
Ferraro, M. ;
Grelli, S. ;
Stillo, M. ;
Magrini, A. .
OCCUPATIONAL MEDICINE-OXFORD, 2019, 69 (02) :143-145
[6]  
Fabianova K, 2018, ZPRAVY CEM SZU PRAHA, V27
[7]  
Fleischmannová J, 2020, EPIDEMIOL MIKROBI IM, V69, P121
[8]  
Griffin DE, 2020, CURR OPIN VIROL, V46, P9
[9]   Anti-science extremism in America: escalating and globalizing [J].
Hotez, Peter J. .
MICROBES AND INFECTION, 2020, 22 (10) :505-507
[10]   The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review [J].
Hughes, Stephanie L. ;
Bolotin, Shelly ;
Khan, Sumaiya ;
Li, Ye ;
Johnson, Caitlin ;
Friedman, Lindsay ;
Tricco, Andrea C. ;
Hahne, Susan J. M. ;
Heffernan, Jane M. ;
Dabbagh, Alya ;
Durrheim, David N. ;
Orenstein, Walter A. ;
Moss, William J. ;
Jit, Mark ;
Crowcroft, Natasha S. .
VACCINE, 2020, 38 (03) :460-469